Jong Min Lee Selected Research

Inflammasomes

10/2019	PF-04620110, a Potent Antidiabetic Agent, Suppresses Fatty Acid-Induced NLRP3 Inflammasome Activation in Macrophages.
1/2019	Circulating Cell-Free mtDNA Contributes to AIM2 Inflammasome-Mediated Chronic Inflammation in Patients with Type 2 Diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jong Min Lee Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 08/2008
14	Myocardial Infarction 04/2021 - 01/2011
14	Cognitive Dysfunction 01/2018 - 11/2011
7	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2011
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 08/2008
6	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 05/2013
5	Atrophy 01/2018 - 02/2014
4	Breast Neoplasms (Breast Cancer) 03/2020 - 05/2012
4	Inflammation (Inflammations) 10/2019 - 10/2016
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2016 - 11/2013
3	Pain (Aches) 04/2022 - 05/2004
3	Acute Kidney Injury (Acute Renal Failure) 10/2021 - 02/2015
3	Stroke (Strokes) 04/2021 - 11/2011
3	Cerebral Small Vessel Diseases 12/2020 - 01/2016
3	Thrombosis (Thrombus) 05/2016 - 10/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2016 - 12/2011
2	Heart Failure 11/2022 - 07/2008
2	Infections 01/2022 - 10/2021
2	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 10/2019 - 01/2019
2	Hypertrophy 09/2019 - 09/2015
2	Insulin Resistance 09/2019 - 05/2016
2	Disease Resistance 02/2019 - 12/2016
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 02/2016
2	Endometrial Neoplasms (Endometrial Cancer) 09/2018 - 11/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 01/2015
2	Wounds and Injuries (Trauma) 09/2017 - 09/2015
2	Edema (Dropsy) 09/2017 - 06/2017
2	Cerebral Cortical Thinning 01/2017 - 01/2015
2	No-Reflow Phenomenon 05/2016 - 08/2014
2	Pathologic Constriction (Stenosis) 10/2015 - 01/2015
2	Atherosclerotic Plaque (Atheroma) 10/2015 - 01/2015
2	Rupture 01/2015 - 09/2012
2	Osteoporosis 01/2015 - 01/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015 - 12/2011
2	Papillary Thyroid Cancer 01/2015 - 12/2012
2	Thyroid Nodule (Nodule, Thyroid) 12/2012 - 08/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2008 - 03/2002
1	Infarction (Infarctions) 06/2022
1	Diabetic Foot 01/2022
1	Ulcer 01/2022
1	Weight Gain 12/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2021
1	Bacteremia 10/2021
1	Sepsis (Septicemia) 10/2021

Drug/Important Bio-Agent (IBA)

17	Amyloid (Amyloid Fibrils)IBA 12/2020 - 05/2013
5	omega-Chloroacetophenone (Mace)IBA 04/2021 - 12/2011
5	HydrogelsIBA 01/2020 - 04/2015
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 08/2008
4	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2016 - 07/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 12/2016
3	Metformin (Glucophage)FDA LinkGeneric 11/2021 - 09/2019
3	graphene oxideIBA 03/2020 - 11/2018
3	GoldIBA 01/2020 - 01/2017
3	Pharmaceutical PreparationsIBA 11/2018 - 01/2006
3	Apolipoproteins E (ApoE)IBA 01/2018 - 11/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 06/2013
3	5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA 10/2016 - 05/2013
3	Amyloid beta-PeptidesIBA 02/2016 - 11/2013
2	Folic Acid (Vitamin M)FDA LinkGeneric 03/2020 - 01/2011
2	InflammasomesIBA 10/2019 - 01/2019
2	EnzymesIBA 09/2019 - 08/2008
2	Apolipoprotein E4IBA 01/2018 - 11/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2017 - 05/2012
2	ApolipoproteinsIBA 01/2017 - 11/2013
2	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 06/2013
2	CalciumIBA 10/2015 - 01/2015
2	Thyroglobulin FDA Link 01/2015 - 08/2010
2	Phenobarbital (Luminal)FDA Link 01/2015 - 01/2012
2	VitaminsIBA 01/2011 - 01/2010
1	Neprilysin (Neutral Endopeptidase)IBA 11/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2022
1	SugammadexIBA 04/2022
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	EndotoxinsIBA 10/2021
1	Polymyxin B (Aerosporin)FDA LinkGeneric 10/2021
1	C-Reactive ProteinIBA 10/2021

Therapy/Procedure

12	Therapeutics 11/2022 - 12/2011
10	Percutaneous Coronary Intervention 04/2021 - 01/2011
6	Stents 05/2016 - 10/2013
5	Photothermal Therapy 03/2020 - 01/2017
4	Lab-On-A-Chip Devices 01/2020 - 04/2015
4	Hysterectomy 01/2019 - 06/2013
3	Adjuvant Chemotherapy 07/2018 - 01/2017
2	Length of Stay 06/2022 - 11/2014
2	Extracorporeal Membrane Oxygenation 10/2021 - 08/2013
2	Chemoradiotherapy 01/2021 - 07/2018
2	Lasers (Laser) 03/2020 - 06/2011
2	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 11/2013
2	Operative Surgical Procedures 01/2017 - 09/2015
2	Aftercare (After-Treatment) 01/2017 - 10/2009
2	Drug Therapy (Chemotherapy) 01/2017 - 01/2015
2	Thyroidectomy 03/2016 - 01/2015
2	Drug-Eluting Stents 03/2016 - 03/2016
2	Radiotherapy 06/2013 - 12/2007
1	Anesthesia 04/2022
1	Debridement 01/2022
1	Artificial Respiration (Mechanical Ventilation) 10/2021
1	Continuous Renal Replacement Therapy 10/2021